The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products
Open Access
- 22 June 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (9) , 2208-2216
- https://doi.org/10.1093/ndt/gfh277
Abstract
Background. Peritoneal dialysis fluids (PDFs) have been shown to alter mesothelial cell functions. To further determine the mechanisms involved, we investigated the effects of glucose, glucose degradation products (GDPs) and advanced glycation end products (AGEs) on the inhibition of human peritoneal mesothelial cell (HPMC) proliferation and the induction of apoptosis and oncosis. Methods. Four PDF solutions, heat-sterilized dextrose-lactate, filtered dextrose-lactate and heat-sterilized dextrose-bicarbonate-lactate, each containing 15 or 45 g/l glucose, and heat-sterilized icodextrin-lactate, containing 75 g/l icodextrin, were tested. In addition, we analysed the independent and synergistic effects of two glucose compounds, i.e. 3-deoxyglucosone (3-DG), a major GDP, and Nε-(carboxymethyl)-lysine (CML), a high-affinity AGE receptor (RAGE) ligand on HPMC viability. Cell proliferation was measured by methyl-[3H]thymidine incorporation. Oncosis was quantified by nuclear propidium iodide (PI) DNA-intercalating capability, and apoptosis by the decrease in mitochondrial transmembrane potential (▵ψm). Results. It was found that heat-sterilized dextrose-lactate inhibited HPMC proliferation to a greater extent than filtered dextrose-lactate, heat-sterilized dextrose-bicarbonate-lactate, or heat-sterilized icodextrin-lactate (PPPPPConclusion. Heat-sterilized PDFs that contain high glucose concentrations and GDPs, which are AGE precursors, reduce cell proliferation, induce mesothelial cell apoptosis and oncosis, and may be involved in peritoneal damage. PDFs containing lower glucose derivative products are more biocompatible.Keywords
This publication has 19 references indexed in Scilit:
- Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoringBiochemical Society Transactions, 2003
- Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentrationKidney International, 2003
- Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cellsKidney International, 2003
- N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patientsDiabetes & Metabolism, 2003
- 3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysisKidney International, 2002
- AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expressionKidney International, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJournal of Clinical Investigation, 2001
- The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial CellsJournal of Biological Chemistry, 2000
- Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.Journal of Clinical Investigation, 1996